688238 logo

Shanghai Obio Technology (Group) Corp., Ltd. Stock Price

SHSE:688238 Community·CN¥3.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688238 Share Price Performance

CN¥5.55
-0.39 (-6.57%)
CN¥5.55
-0.39 (-6.57%)
Price CN¥5.55

688238 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with minimal risk.

1 Risk
0 Rewards

Shanghai Obio Technology (Group) Corp., Ltd. Key Details

CN¥265.4m

Revenue

CN¥300.3m

Cost of Revenue

-CN¥35.0m

Gross Profit

CN¥193.7m

Other Expenses

-CN¥228.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.36
-13.17%
-86.16%
30.2%
View Full Analysis

About 688238

Founded
2013
Employees
715
CEO
Oudong Pan
WebsiteView website
www.obiosh.com

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytical methods, IND-enabling chemistry, manufacturing, and controls; and clinical and commercial manufacturing for viral vector, oncolytic virus, and cell therapy products. The company was formerly known as Obio Technology (Shanghai) Corp., Ltd. and change its name to Shanghai Obio Technology (Group) Corp., Ltd. in March 2026. The company was founded in 2013 and is headquartered in Shanghai, China.

Recent 688238 News & Updates

Recent updates

No updates